-MicroRNAs (miRNAs) play a significant role in ischemic heart disease. Animal models of left ventricular (LV) ischemia demonstrate a unique miRNA profile; however, these models have limitations in describing human disease. In this study, we performed next-generation miRNA and mRNA sequencing on LV tissue from nine patients undergoing cardiac surgery with cardiopulmonary bypass and cardioplegic arrest. Samples were obtained immediately after aortic cross clamping (baseline) and before aortic cross clamp removal (postischemic). Of 1,237 identified miRNAs, 21 were differentially expressed between baseline and postischemic LV samples including the upregulated miRNAs miR-339-5p and miR-483-3p and the downregulated miRNA miR-139-5p. Target prediction analysis of these miRNAs was integrated with mRNA expression from the same LV samples to identify anticorrelated miRNA-mRNA pairs. Gene enrichment studies of candidate mRNA targets demonstrated an association with cardiovascular disease, cell death, and metabolism. Therapeutics that intervene on these miRNAs and their downstream targets may lead to novel mechanisms of mitigating the damage caused by ischemic insults on the human heart. microRNA; myocardial infarction; mRNA; sequencing MYOCARDIAL ISCHEMIA IS a life-threatening event that involves a mismatch between oxygen supply and demand. It can occur in many contexts including atherosclerosis, coronary artery spasm, vasculitis, and during cardiac surgery with cardiopulmonary bypass (CPB) (17, 34). Ischemia initiates several biological processes including altered metabolism, initiation of apoptosis, necrosis and fibrosis, and long-term adaptive responses such as angiogenesis, inflammation, and remodeling (39). These changes are highly dependent on genetic, transcriptional, and translational variation. In particular, regulation by miRNAs has recently been shown to play a significant role in the biology of myocytes undergoing ischemia (1, 48).
MYOCARDIAL ISCHEMIA IS a life-threatening event that involves a mismatch between oxygen supply and demand. It can occur in many contexts including atherosclerosis, coronary artery spasm, vasculitis, and during cardiac surgery with cardiopulmonary bypass (CPB) (17, 34) . Ischemia initiates several biological processes including altered metabolism, initiation of apoptosis, necrosis and fibrosis, and long-term adaptive responses such as angiogenesis, inflammation, and remodeling (39) . These changes are highly dependent on genetic, transcriptional, and translational variation. In particular, regulation by miRNAs has recently been shown to play a significant role in the biology of myocytes undergoing ischemia (1, 48) .
MicroRNAs (miRNAs) are small noncoding RNAs that bind through their "seed" region (nucleotides 2-7) to the 3=-untranslated region (3=-UTR) of mRNAs and repress their protein expression (2) . Over 30% of all human genes are thought to be regulated by miRNAs, and some miRNAs can potentially target hundreds of mRNAs; thus it is not surprising that dysregulation of these small RNAs can play a large role in many disease processes (26) . Though the changes in cardiac miRNA expression resulting from ischemic heart disease have been described in animal models, they demonstrate significant variability that can be attributed to several factors, including the species, the mechanism and timing of ischemia and reperfusion, and many others (1, 48) . Human studies thus far have limitations because results are derived from cell lines or postmortem tissue samples from transplant donors or following fatal myocardial infarction (5, 40) . Even more studies have quantified heart-specific miRNAs in circulating blood following acute cardiac injury in humans, though tissue specificity plays a major role in determining transcriptional responses and none were performed in human myocardium (33, 47) . As a result, there is a paucity of information regarding the acute changes in human cardiac-specific miRNA expression that occur in vivo following ischemia.
To better define these changes, we performed whole-genome miRNA sequencing (miRNA-seq) as well as whole-genome mRNA sequencing (mRNA-seq) of left ventricular (LV) myocardium in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) at two time points, at baseline and after an average of 81 min of cold, cardioplegic arrest. Many studies have shown that during this window of arrest, the human heart experiences myocardial injury as demonstrated by a significant release of cardiac specific biomarkers (10, (23) (24) (25) . We identified miRNAs that were differentially expressed between the baseline and postischemic samples and matched them with their predicted mRNA targets. This allowed us to identify specific RNA regulatory networks that define cardiac injury. Insight into these molecular perturbations may help clinicians develop novel therapeutics to limit the adverse effects of ischemia after acute myocardial injury.
MATERIALS AND METHODS
Patients and tissue samples. We prospectively enrolled nine patients undergoing nonemergent aortic valve replacement surgery with CPB (Table 1) . Procedures were performed in accordance with the ethical standards of The Partners HealthCare Institutional Review Board, which approved this study, and written informed consent was obtained from each patient. Punch biopsies (ϳ3-5 g total RNA content) were taken from the LV apex at two time points: immediately after initiation of CPB at the time of routine placement of a surgical vent (baseline) and after a median of 81 min [interquartile range (IQR) 59 -99 min] (postischemia), during which time the heart was arrested with cold blood cardioplegia for myocardial protection.
miRNA and mRNA sequencing. Tissue samples were immediately placed in RNAlater (Ambion, Life Technologies) at ϩ4°C for 48 h and then frozen at Ϫ80°C until RNA extraction. Total RNA was isolated with Trizol, and RNA quality was assessed using the Agilent Bioanalyzer 2100 (Agilent, Santa Clara, CA). Median RNA integrity number score was 6.5 (IQR 5.8 -7.0) across all samples. For mRNA library preparation, ribosomal RNA was removed by performing one or two washings of RNA annealed to poly-T oligo beads (Invitrogen; Life Technologies, Grand Island, NY). RNAs were fragmented and then reverse-transcribed using random hexamers (Invitrogen). Double-stranded DNA (dsDNA) synthesis was performed using Pol I and RNase H. Short fragments were purified with QiaQuick PCR extraction kit (Qiagen, Hilden, Germany) and resolved with elution buffer for end reparation and poly(A) addition then ligated with sequencing adaptors for cluster generation and sequencing on the Illumina HiSeq 2000 (Illumina, San Diego, CA). For miRNA library preparation, RNA was separated by polyacrylamide gel electrophoresis, and the 18 -30 nucleotide stripe was selected. After adaptor ligation, small RNAs were reverse-transcribed. PCR products were then resolved by polyacrylamide gel electrophoresis and dissolved in elution solution prior to Illumina sequencing.
We chose a read length of 91 base pair paired-end sequencing with an average of 60 million reads per sample for our mRNA-seq experiment, while for the much smaller miRNAs, we used 50 base pair single-end reads with 15-30 million reads per sample.
Alignment. Raw reads produced by the Illumina sequencer imaging files were filtered to remove reads containing adaptor sequences, containing Ͼ5% unknown nucleotides, or having Ͼ50% of reads with base quality scores Ͻ5. Cleaned and trimmed miRNA reads were aligned to the human reference genome (UCSC hg19) using Bowtie2 (20) with default parameters and allowing for 0 mismatches. To identify miRNAs, samples were subsequently aligned to miRBase 20 (18) . Only fully overlapped reads were counted in the annotation, and the reads of those miRNAs with multiple genetic loci but identical mature sequences were grouped together. For mRNA analysis, cleaned and trimmed mRNA were similarly aligned to the human reference genome (UCSC hg19) using Tophat version 2.0.5 and Bowtie2 and subsequently annotated by RefSeq. Mate inner distance was set at 165 bp and mate standard deviation at 37 bp. Default parameters were used for all other settings. For both miRNA and mRNA, analysis on aligned BAM files was performed using Partek Genomics Suite (PGS) version 6.6 (Partek).
Differential expression. Significant differentially expressed miRNAs were determined by a paired t-test analysis within PGS. Nonparametric paired analysis was also performed and yielded similar results (data not shown). Only miRNAs with mean normalized expression from all samples Ͼ 0.1 reads per million mapped reads were analyzed to avoid miRNAs with zero reads in many paired samples. miRNAs with a P value Ͻ 0.05 were considered significant.
miRNA-mRNA correlation studies. Sequence-based predicted mRNA targets were obtained from TargetScan 6.2 (http://www. targetscan.org) and MirDB (http://www.mirdb.org), which rely on specific miRNA targeting criteria including complementarity to the "seed" region. Two miRNAs had no targets in either database and were thus removed from further analysis. Pearson correlation coefficients were then generated for each differentially expressed miRNA and all mRNA using PGS. Nonparametric Spearman's rank correlation was also conducted and yielded similar results (data not shown). A cutoff mean mRNA expression from all samples of 1 read per kilobase per million mapped reads was used to avoid mRNAs with no reads or low read abundance in multiple samples. Concordance between the predicted targets and the expression data was assayed using density plots that compare the distribution of Pearson correlation coefficients of all predicted mRNA targets to a control distribution of randomly selected nonpredicted target mRNAs for each differentially expressed miRNA. Those miRNAs with correlation coefficients of predicted targets shifted to the left (more negative) were considered significant compared with the control if the calculated t-test P value was Ͻ 0.05. Density plots were constructed using JMP version 10 (SAS Institute, Cary, NC).
miRNA target functional analysis. Pearson correlation coefficients of differentially expressed miRNAs and their anticorrelated predicted targets were considered significant if their corresponding q-value was Ͻ 0.1. The q-value was calculated using a false discovery rate as the proportion of false positives among all positives (38) . Target functional studies were performed with Ingenuity Pathway Analysis (IPA; Ingenuity Systems, Redwood City, CA; http://www.ingenuity.com). Associations with P value Ͻ 0.05 were considered significant.
Reverse-transcription PCR and real-time quantitative PCR. Reverse-transcription (RT)-PCR and real-time quantitative PCR were performed using the miScript PCR system (Qiagen) according to the manufacturer's protocol on five paired baseline and postischemic LV samples. These samples were distinct from those samples used for sequencing and had a median aortic cross-clamp time of 95 min. Briefly, RNA was extracted as described above. We used 2 g of RNA with miScript II RT Kit reagents to generate cDNA. We subsequently diluted 20 l RT reactions with the addition of 200 l of RNase-free water and 1 l of the diluted mix was used with miScript SYBR Green PCR Kit reagents for real-time quantitative PCR using the Applied Biosystems StepOnePlus system. miScript Primer Assays for miR-139-5p (UCUACAGUGCACGUGUCUC-CAGU), miR-339-5p (UCCCUGUCCUCCAGGAGCUCACG), and miR-483-3p (UCACUCCUCUCCUCCCGUCUU) were used for specific primers along with the universal primer. The human RNU6B control included in the kit was used for normalization. Reactions were performed in triplicates and C T values were averaged. High efficiency and specificity were established with standard curves and melting curves, respectively. Comparative analysis between postischemic and baseline samples was performed by the ⌬C T method (⌬CT ϭ CT of the miRNA Ϫ CT of RNU6B) with 2ˆ(Ϫ⌬CT) transformation using JMP version 10.
RESULTS
LV miRNA profile. We generated 15-30 million reads for each sample. Of all the reads, 64.0% mapped to 1,237 out of 2,772 known miRNAs in miRBase version 20. The average normalized expression of baseline and postischemic miRNAs correlated strongly, validating the precision of our sequencing and alignment (Fig. 1) . Likewise, the most highly expressed miRNAs were also identified as highly abundant in other miRNA expression profiles of cardiac tissue (Table 2) , and similarly, a small number of miRNAs comprised the majority of reads (16, 21) ; 68 and 70% of all reads are derived from the top five highly expressed miRNAs in the baseline and postischemic samples, respectively.
Differential expression of miRNAs. Paired differential expression analysis of 588 miRNAs resulted in 21 significantly dysregulated miRNAs (Table 3) . Of these, 13 were upregulated in the postischemic samples compared with baseline, and eight were downregulated. Fold change varied between 1.4 and 6.6, with 14 miRNAs having a fold change Ͼ 2. Real-time quantitative PCR on the differentially expressed miRNAs miR-139-5p, miR-339-5p, and miR-483-3p correlated with our sequencing data (Fig. 2) .
LV mRNA profile. An average of 60 million reads were generated from each sample, which aligned to 41,289 of the 48,539 transcripts in the RefSeq database. Specifically, on average 52.9% of the reads overlapped completely within exons and 3.8% mapped to introns.
Correlation of miRNA and mRNA expression. The list of mRNAs that could serve as direct miRNA targets, generated by TargetScan 6.2 and MirDB, was further refined by conducting pair-wise Pearson correlation coefficient analysis between each differentially expressed miRNA and its predicted mRNA targets. Since miRNAs negatively regulate mRNAs, we would expect a left shift in the predicted target distribution toward the negative correlations compared with the control. Indeed, seven out of 19 miRNAs, including the strongly dysregulated miR- The top 10 microRNAs (miRNAs) by mean reads per million mapped reads (RPM) are shown for both the baseline and postischemia groups. miRNA are sorted from most abundant to least abundant. The top differentially expressed miRNAs with P value Ͻ 0.05 are shown. Only those miRNAs with mean RPM Ͼ 0.1 were considered for differential expression analysis. †miR-148a-5p, miR-27a-5p, and miR-625-3p were previously annotated miR-148a*, miR-27a*, and miR-625*, respectively, signifying a mature miRNA that is less abundant than the miRNA originating from the opposite arm of the same pre-miRNA. 139Ϫ5p, miR-483Ϫ3p, and miR-339Ϫ5p, had a significant shift (Fig. 3) . We chose the miRNAs miR-483Ϫ3p and miR-339Ϫ5p for further target analysis as they were the most significantly dysregulated miRNAs with fold change Ͼ2 and a left-shifted density plot. The 14 most significant anticorrelated predicted targets of these miRNAs by Pearson correlation coefficient q-value Ͻ 0.1 are listed in Table 4 . All pairs in this list have a negative correlation where high levels of the miRNA are associated with low levels of its target mRNA. Of note, mRNA sequencing data was available from two of the five additional paired samples used for real-time quantitative PCR. In these samples, all 14 predicted mRNA targets described above were also downregulated in postischemic samples compared with baseline (data not shown).
miRNA target functional analysis. IPA gene enrichment studies of these 14 targets showed that the most significant association under the category "disease" was cardiovascular ( Table 5 ). The most significant "molecular and cellular function" was cell death and survival. In fact, 12 out of 14 targets ( namely KIF1B, CACNB2, PPARGC1B, SIRT4, USP8, OGT,  SGCD, UBE3A, NFE2L1, BCLAF1, SLC1A3, and SATB1) have been linked to cell death. IPA also associated all 14 targets in the network "integrated lipid metabolism, small Fig. 3 . Distribution of Pearson correlation coefficients of predicted miRNA-mRNA pairs. For each miRNA, we determined the correlation between the expression of that miRNA and the expression of a predicted mRNA target in all samples (n ϭ 18) by calculating a Pearson correlation coefficient. This was repeated for all mRNA targets of that miRNA, and the distribution of these coefficients (blue line) is illustrated in a density plot. The control curve (red line) describes the distribution of an equal number of coefficients where each coefficient is derived from the correlation between the expression of that miRNA and the expression of a random (not a predicted target) mRNA. A left shift of the blue compared with the red curve indicates that predicted targets are preferentially more anticorrelated with that miRNA than random mRNAs. Only those miRNAs with a significant shift (by t-test P value Ͻ 0.05) are shown.
molecule biochemistry, and cell death and survival" (Fig. 4) . Central nodes of this network include AKT, calcium, and UBC (ubiquitin), which function as master regulators of these pathways. These enrichments in cardiovascular disease, proliferation, cell death, and metabolism correlate well with pathways expected to be altered following cardiac ischemia.
DISCUSSION
We examined the whole-genome miRNA and mRNA expression profile of LV tissue at baseline and immediately following myocardial injury in the human heart. The most abundant miRNAs in our samples are among the most highly expressed miRNAs in previously published human LV profiles (16, 21) . A total of 21 miRNAs were differentially expressed after ischemia. We used sequence-based databases to generate a list of predicted targets of dysregulated miRNAs and used the mRNA expression profile to identify candidate miRNAmRNA pairs that have a role in myocardial injury. Functional analysis of these putative targets demonstrated enrichment in cardiovascular disease, cell death, and metabolism, which aligns with pathways expected to be activated during an ischemic insult.
Of the 21 significantly dysregulated miRNAs, only miR139Ϫ5p, the most statistically significant differentially regulated miRNA in our study, has been previously described as being differentially expressed in other cardiac ischemia/reperfusion models. Most of our functional understanding of miR- 139Ϫ5p is derived from cancer research where it has been shown to have anti-invasive and antiproliferative properties toward certain malignancies including hepatocellular carcinoma (9), colorectal cancer (12) , and breast cancer (19) . With respect to cardiac ischemia, miR-139Ϫ5p is downregulated in the border zone of infarcted mouse hearts 14 days after insult (40) . In human autopsy samples, miR-139Ϫ5p was downregulated earlier, within just 7 days following myocardial infarction (4) . Similarly, in our human biopsies miR-139Ϫ5p was also downregulated immediately following ischemic insult. miRNAs function by binding to the 3=-UTR of mRNAs and repressing their translation (2) . There are many strategies used to try and uncover bona fide mRNA targets of miRNAs, and while experimental methods might be considered ideal, there are far too many putative interactions to rely on this approach alone. Fortunately, sequence-based methods have proven to be useful to reduce the number of candidate targets to a manageable list worth the resources of experimental validation. Even more, by combining computational strategies with high-throughput expression profiles, we can further refine a collection of putative miRNA-mRNA interactions. Our approach of combining data from target prediction databases with Pearson correlation coefficient analysis of miRNA and mRNA expression has been used by other authors as well, with comparable success to other methods that filter sequence-based predictions using expression data (26, 27, 37, 49) . One way to demonstrate concordance between these two methods is to plot density plots of correlation coefficients (43) . Since miRNAs downregulate their target mRNAs, one would expect predicted targets to have significantly more negative correlation coefficients than a control distribution of nonpredicted target mRNAs. Indeed, we demonstrated this enrichment for almost half of the miRNAs analyzed.
We focused our target analysis on the upregulated miRNAs, miR-339Ϫ5p and miR-483Ϫ3p, as they were the most highly dysregulated miRNAs with annotated targets and fold change Ͼ 2. Furthermore, when the correlation between all differentially expressed miRNAs and their predicted targets was calculated, 14 out of the top 15 anticorrelated mRNAs with q-value Ͻ 0.1 were paired with either miR-339Ϫ5p or miR-483Ϫ3p, thus validating our selection criteria. Although miR-139Ϫ5p may appear to be an attractive candidate for additional analysis, its low fold change and lack of significant anticorrelated targets in our mRNA-seq data precluded further investigation. We also did not perform a more comprehensive analysis of the remaining downregulated miRNAs with fold change Ͼ 2, because they also lacked significant anticorrelated targets.
In humans, upregulation of miR-339Ϫ5p causes antiproliferative and anti-invasive phenotypes in breast cancer through the inhibition of the BCL-6 oncogene (44) and in colon cancer through the inhibition of the PRL-1 oncogene (46) . It also has recently been shown to be upregulated in mouse models of ischemic stroke (8) and downregulated in the developing mouse heart (22) . miR-483Ϫ3p is another well-studied miRNA in human cancers although its exact role might be tissue specific. It has been described as having tumor suppressor function through the inhibition of cell cycle and antiapoptotic genes in squamous cell carcinomas (3), as well as oncogenic potential through the inhibition of the proapoptotic protein PUMA in human liver carcinoma cell lines (41) . Even more, the transforming growth factor (TGF)-␤-associated SMAD4 mRNA was validated as a direct target of miR483Ϫ3p, and this relationship was shown to contribute to the progression of pancreatic cancer (15) . TGF-␤ is a well-characterized regulator of many postischemic events in the heart (6), and these effects have the potential to be fine-tuned by miRNA regulation. Interestingly, SMAD4 was also strongly anticorrelated with miR-483Ϫ3p in our study (P value ϭ 0.003) and deserves further experimental investigation. Regardless, both miR-339Ϫ5p and miR-483Ϫ3p seem to play a role in survival and proliferation, which would be expected of regulators of acute cardiac ischemia. This was further substantiated by IPA functional enrichment of their significantly anticorrelated predicted targets. Under the category molecular and cellular functions, cell death and survival was the most significant association, and under the category "toxicities," cardiac necrosis/cell death was at the top of the list.
IPA also placed all 14 targets in one network (Fig. 4) with several linker molecules involved in cellular biochemistry and metabolism. For example, the target PPARGC1B is a coactivator of gene transcription that regulates many metabolic functions of the mitochondria, including fuel transport, energy consumption, angiogenesis, and prevention of reactive oxygen species. This coactivator in turn is regulated by many environmental cues such as hypoxia, exercise, and aging, through posttranslation modification. Many of the enzymes that catalyze these modifications are also in this network including the target OGT, an O-linked N-acetyl-␤-D-glucosamine (O-GlcNAc) transferase, and the linker AKT, a serine/threonine protein kinase (29) . OGT also directly modifies AKT in order to regulate insulin signaling and glucose uptake (36) . The target SIRT4 is a member of the sirtuin family that is also located in the mitochondria and seems to be involved in fat metabolism (11) . Lastly, CACNB2 encodes a subunit of an L-type voltagedependent calcium channel. Calcium is a key modulator of many biochemical processes, in addition to contributing to the cardiac myocyte action potential (42) . It is not surprising that during the oxygen-deprived state of cardiac ischemia there are changes in cellular biochemistry and metabolism. Some of these alterations might be protective to the heart, but others may represent maladaptive changes that lead to long-term dysfunction (35) . As a result, these components of metabolism serve as potential targets for mitigating the damage of ischemic insult.
Another central hub of this network is the linker ubiquitin, which is associated with the targets UBE3A, a ubiquitin ligase, and USP8, a deubiquitinating enzyme. The ubiquitin-proteasome pathway controls the degradation of many intracellular proteins. Several studies have reported dysregulation of this pathway following myocardial ischemia and ischemic preconditioning (7, 14, 32) . The use of proteasome inhibitors to counteract the damage of myocardial injury has been equivocal (31, 45) . Nevertheless, inhibition of specific enzymes of this pathway, as opposed to those that inhibit multiple components, could be therapeutic and requires further investigation.
Two of the 21 differentially expressed miRNAs, miR6515Ϫ5p and miR-6509Ϫ5p, had no predicted targets in any databases listed in miRBase. As a result, they were not included in the functional analysis. Nevertheless, both of these targets were upregulated Ͼ6-fold in baseline vs. postischemic samples and thus may be functionally significant regulators of myocardial injury. For example, when we compared the ex-miRNA EXPRESSION OF THE ISCHEMIC HUMAN HEART pression of miR-6515Ϫ5p to all mRNA, the strongest positive and negative correlated mRNAs were functionally enriched in RNA processing (data not shown). These mRNAs could be true direct or indirect targets of miR-6515Ϫ5p that may represent novel pathways of injury amenable to therapeutic intervention.
There are several possible explanations for why we did not observe predominately anticorrelated miRNA and target mRNA relationships for some differentially expressed miRNAs. Perhaps the ischemic time was too short to allow for complete targeting, especially since we do not expect small changes in endogenous miRNAs to cause large changes in mRNAs that might, for example, be seen with overexpression assays. Also, there is still a considerable amount of debate regarding the relative contribution of mRNA destruction vs. direct inhibition of translation in the regulatory role of miRNAs (13, 49) . Furthermore, some studies have shown that miRNAs can increase translation of their targets (28, 30) , and other mechanisms that regulate mRNA stability may be more influential than miRNA repression after acute ischemia. Moreover, we understand that our model for induced ischemia, cold cardioplegic arrest, is not a perfect corollary of acute human ischemia as it does confer a degree of protection. However, given the amount of cardiac-specific biomarkers released we do feel that it is an approximation, though our results might underestimate the true extent of ischemic injury.
In conclusion, we described the global miRNA expression profile of baseline and postischemic human LV cardiac tissue. Differential expression analysis identified candidate miRNAs that are dysregulated following ischemia. Lastly, whole-genome mRNA expression data were used to strengthen the candidacy of sequence-based predicted targets of miRNAs in order to identify putative miRNA-mRNA pairs that may function in myocardial injury.
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